戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 by the addition of 2.5% phenylephrine and 1% tropicamide.
2 raction after cycloplegia with 2 drops of 1% tropicamide.
3 inducement of cycloplegia with 2 drops of 1% tropicamide.
4 octramine but not to 4-DAMP, pirenzepine, or tropicamide.
5 EK autorefractor with administration of 0.5% tropicamide.
6 ropicamide, or 1% hydroxyamphetamine / 0.25% tropicamide.
7 rect MSNs mediate the antiakinetic action of tropicamide.
8 h gradually releases the active ingredients: tropicamide (0.25 mg) and phenylephrine (5.38 mg).
9 illary mydriasis with phenylephrine 2.5% and tropicamide 1% administered via standard eye drops compa
10 re randomized to either cyclopentolate 1% or tropicamide 1% in the first visit with autorefraction me
11 .In all groups oxybuprocain 0.4%, cocain 4%, tropicamide 1%, phenylephrine 10%, diclophenac 0.1% alon
12                                              Tropicamide (1%) is an effective cycloplegic agent in my
13 rinic antagonists atropine, scopolamine, and tropicamide (1-2 microM) caused substantial decreases of
14  Mydriasert compared to mydriatic eye drops (tropicamide [1%] plus phenylephrine [10%]).
15  1% tropicamide and then a second drop of 1% tropicamide 4 to 6 minutes later.
16                   Dilation of the pupil with tropicamide alone had no effect on the rate of clearance
17                     However, scopolamine and tropicamide also produced increases in non-specific acti
18                After pupil dilation with 1 % tropicamide and 10 % phenylephrine for retinal examinati
19 rated that an ophthalmic spray containing 1% tropicamide and 2.5% phenylephrine was non-inferior to t
20   Provocative testing with mydriatic agents (tropicamide and atropine 1%) caused significant increase
21 angles was low after pupillary dilation with tropicamide and oral acetazolamide prophylaxis.
22               Dilation with a combination of tropicamide and phenylephrine caused clearance of fluore
23  eye followed 1 minute later by 1 drop of 1% tropicamide and then a second drop of 1% tropicamide 4 t
24  images were ungradable, reflex dilation (1% tropicamide) and mydriatic photography were performed fo
25 d using 1 drop each of 1% cyclopentolate, 1% tropicamide, and 2.5% phenylephrine.
26 raction after cycloplegia with 2 drops of 1% tropicamide at each annual visit.
27 roM muscarinic antagonists methoctramine and tropicamide but not by pirenzepine.
28  topical, ocular, ophthalmic, phenylephrine, tropicamide, cardiovascular effect, side effect, blood p
29                                              Tropicamide caused large decreases in firing after DFP,
30                     Lastly, we observed that tropicamide causes a significant decrease in the percent
31           Compared with placebo and with the tropicamide control, ibopamine decreased intraocular pre
32 mber, an effect that was not associated with tropicamide during its peak mydriasis.
33                                              Tropicamide exhibited the most robust statistical signif
34 ll subjects underwent pupil dilation with 1% tropicamide eye drops at the baseline visit, before any
35  SE after instillation of cyclopentolate and tropicamide in both eyes was 1.07+/-5.2 and 0.96+/-5.1,
36     To evaluate the cycloplegic effect of 1% tropicamide in myopic children and to determine whether
37 lts from the open field assay indicated that tropicamide increases activity in both the WT and KO mic
38 ype-selective antagonists biperiden (M1) and tropicamide (M4).
39 , 8.1) > hexahydrosiladiphenidol (M3, 8.0) > tropicamide (M4, 6.4) > pirenzepine (M1, 6.1) > methoctr
40                                              Tropicamide might be an effective and safe replacement f
41 upil dilation with 2.5% phenylephrine and 1% tropicamide, ocular alignment was remeasured in primary
42 nstillation of either 2.5% phenylephrine, 1% tropicamide, or 1% hydroxyamphetamine / 0.25% tropicamid
43 +/-1.2 for cyclopentolate and 1.04+/-1.2 for tropicamide (P value < .001).
44 mal human volunteers underwent dilation with tropicamide, phenylephrine, and a combination of the two
45  M1 and M4 mAChR antagonists telenzepine and tropicamide, respectively, were tested in the same model
46 than that of pirenzepine, methoctramine, and tropicamide to inhibit the contractile response to musca
47 ss this hypothesis we used an M4 antagonist, tropicamide, to reduce the activity through the M4 mAChR
48 rom the marble-burying assay have shown that tropicamide treatment resulted in a decreased number of
49              In the passive avoidance assay, tropicamide treatment resulted in the improvement of per
50 erence between DeltaSE of cyclopentolate and tropicamide was found statistically significant at 0.11+
51    The greatest effect of cyclopentolate and tropicamide was in hyperopic eyes with DeltaSE of 1.54+/
52             The anti-parkinsonian effects of tropicamide were almost completely abolished in mutant l
53                          Three drops of 0.5% tropicamide were used to obtain the cycloplegic refracti
54  and its effects were compared with those of tropicamide, with and without dapiprazole in a double-ma